Navigation Links
Trading Of Onyx Pharmaceuticals Common Stock Halted
Date:6/20/2012

SOUTH SAN FRANCISCO, Calif., June 20, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced that NASDAQ has halted trading of the company's common stock.   The U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) is meeting this afternoon to discuss the company's New Drug Application (NDA) for Kyprolis™ (proposed brand name for carfilzomib) under the accelerated approval pathway.

The NDA for Kyprolis for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior therapies that included a proteasome inhibitor and an immunomodulatory agent is currently being reviewed by the U.S. FDA, and the anticipated date for completion of review under the PDUFA guidelines is July 27, 2012.

Conference Call Today
The Onyx management team will host a webcast and conference call to discuss the ODAC recommendation today at 7:00 p.m. Eastern Time (4:00 p.m. Pacific Time).

To access a live audio webcast of the conference call, log onto the company's website at: http://www.onyx.com/investors/event-calendar.

To access the live conference call, dial (847) 585-4405 and use the passcode 32594605. A replay of the call will be available on the Onyx website or by dialing (630) 652-3042 and using the passcode 3259 4605# approximately two hours after the conference call concludes through July 4, 2012.

About Onyx Pharmaceuticals, Inc.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's we
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. American Oriental Bioengineering Inc. Announces Suspension of Trading in its Common Stock and the Initiation of Delisting Proceedings by NYSE
2. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
3. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
4. ADVENTRX Pharmaceuticals To Present At 2012 BIO International Convention Business Forum
5. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
6. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
7. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
8. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
9. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
10. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
11. Valeant Pharmaceuticals To Host Investor Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)...   MultiVir Inc. ("MultiVir"), a clinical-stage gene ... for the treatment of multiple oncological indications, today announced ... Form S-1 with the U.S. Securities and Exchange Commission ... shares of its common stock. The number of shares ... proposed offering have not yet been determined. MultiVir has ...
(Date:3/30/2015)... , March 30, 2015   CSL ... Agency (EMA) has started the Centralized Procedure for ... its long-acting fusion protein linking recombinant coagulation factor ... approval, rIX-FP will provide hemophilia B patients in ... European Economic Area (EEA) countries, with a long-acting ...
(Date:3/30/2015)... SAN DIEGO , March 30, 2015 ... the appointment of George K. Ng to ... Officer.  In this capacity, Mr. Ng will be responsible ... Mr. Ng joins the Company from BioDelivery Sciences ... General Counsel and a member of senior management that ...
Breaking Medicine Technology:MultiVir Files Registration Statement for Proposed Initial Public Offering 2European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 2European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 3European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 4Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 3
... , NEW YORK, Oct. 13 Reportlinker.com ... is available in its catalogue. , ... Outlook to 2010: Marketing and Sales Strategies ... , http://www.reportlinker.com/p0154807/Reportlinker-Adds-Global-Drug-Manufacturing-Industry-Outlook-to-2010-Marketing-and-Sales-Strategies-and-the-Impact-of-Recession-and-Recovery.html ...
... , PHILADELPHIA, October 13 ... specialty biopharmaceutical company, announces,that it has settled all pending ... New Drug Application ("ANDA") and its,attempt to market generic ... treatment of Attention Deficit Hyperactivity,Disorder. , ...
Cached Medicine Technology:Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 2Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 3Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 4Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 5Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 6Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 7Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 8Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 9Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 10Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 11Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 12Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 13Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 14Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 15Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 16Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 17Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 18Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 19Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery 20Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R) 2Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R) 3
(Date:3/30/2015)... Software applications from five global ... second AS4 test and certification event, announced today ... interoperability software testing. New software applications from Axway, ... in this vendor-neutral test event which began in ... certifications for IBM, Oracle and Software AG, joining ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 People from all ... verified benefits of meditation -- yet want a refreshingly simple ... guidance “on-demand” with the new app MindBody Sessions. The app ... at http://www.mindbodysessions.com , or it can be downloaded for ... Google Play . , Developed by MindBody Sessions LLC, ...
(Date:3/30/2015)... 2015 Corra Group is continuing to add ... of every industry that requires this form of background ... seek new ways to increase productivity and cut down on ... will help detect substance abuse with a wide range of ... said Corra Group Co-Founder, Gordon Basichis. “The Healthcare ...
(Date:3/30/2015)... Considered to be the best assessment tool ... business community, this next generation of the IT ... big data and frameworks with virtually endless possibilities. These ... and logic features are a technological force to be ... said “The IT Audit Machine is just one of ...
(Date:3/30/2015)... London, UK (PRWEB) March 30, 2015 ... data and analytics professionals search for their next career ... over the next few years for those with skills ... site, at http://www.1potato.com , is a jobs aggregator, ... around the globe and indexing them individually to help ...
Breaking Medicine News(10 mins):Health News:Latest AS4 Standard-Based Products Drummond Certified™ 2Health News:Latest AS4 Standard-Based Products Drummond Certified™ 3Health News:New Web, iOS and Android App “MindBody Sessions” Makes Mindfulness and Meditation Easy 2Health News:New Web, iOS and Android App “MindBody Sessions” Makes Mindfulness and Meditation Easy 3Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 2Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 3Health News:Building on Success: Next Generation of Cyber Crime Prevention Unveiled! 2Health News:New Global Job Site Launched for Big Data and Analytics Job Seekers 2
... As cancer researchers continue to identify genetic mutations ... a catalog of possible targets for new treatments. ... Center and Michigan Center for Translational Pathology (MCTP) ... the practical challenges involved in quickly and systematically ...
... an inflammatory mechanism known as inflammasome may lead to ... a heart attack, pointing researchers toward developing more targeted ... a heart attack, an inflammatory process occurs in the ... This process helps the heart to heal, but may ...
... , WEDNESDAY, Nov. 30 (HealthDay News) -- Toddlers who take ... not have HIV, a new study shows. It,s the ... unknown, according to the U.S. National Institutes of Health researchers ... children who had been exposed to HIV in the womb. ...
... (Nov. 30, 2011) A study led by the ... family caregivers are "second order patients" themselves and require ... in a recent issue of Qualitative Health Research ... researchers recorded discussions between hospice caregivers and the intervention ...
... , WEDNESDAY, Nov. 30 (HealthDay News) -- Eating baked or ... brain health and lower the risk for mild cognitive impairment ... study authors found that eating baked and broiled fish -- ... strengthening them in areas of the brain deemed critical to ...
... and testing data corresponding to specific meat, poultry, and ... "substantial benefits," including the potential to favorably impact public ... Council. The report adds that the release of ... valuable insights that go beyond the regulatory uses for ...
Cached Medicine News:Health News:Genetic sequencing could help match patients with biomarker-driven cancer trials, treatments 2Health News:Genetic sequencing could help match patients with biomarker-driven cancer trials, treatments 3Health News:Researchers examine role of inflammatory mechanisms in a healing heart 2Health News:Toddlers Taking HIV Drugs Have Higher Cholesterol 2Health News:Study shows hospice caregivers need routine care interventions 2Health News:Non-Fried Fish Might Help Ward Off Alzheimer's: Study 2Health News:Non-Fried Fish Might Help Ward Off Alzheimer's: Study 3Health News:Publicly releasing inspection data on meat processing facilities could have 'substantial benefits' 2Health News:Publicly releasing inspection data on meat processing facilities could have 'substantial benefits' 3
... Anatomically Correct Design Is Unique Among All ... Gently Support The Lids Through An Anatomically Correct ... Contrasts With All Other Lid Speculums Which Pull ... The Tarsal Plate As They Open. Gentle ...
... Design Holds The Lens Securely During ... Blades Keep The Optic From Being ... Over Release Of The Optic.,Wide Jaw ... During Insertion.,Reusable, Autoclaveable, Made In The ...
... Designed To Dial An Exact Extension Of ... Maximum Visibility, With Titanium Handle & Spring. ... In Tissue, And Can Also Be Dialed ... Autoclaveable, Made In The USA, Handle Guaranteed ...
... Unique 23g Tube Allows Use Through ... A More Comfortable Approach To The ... The Capsule To Initiate And Complete ... In Weight For Improved Ergonomic Feel. ...
Medicine Products: